New AI Test Predicts Mortality Risk in Metastatic Prostate Cancer
The digital pathology platform provides patient-specific risk estimates to help clinicians tailor treatment for metastatic hormone-sensitive disease.
Category: Prostate
Prostate
Latest
Prostate
Latest
FDA Approves Blood-Based Prostate Cancer Test
The test receives premarket approval as an aid in biopsy decision-making for men 50 and older with elevated PSA levels.
Prostate
Latest
FDA Grants De Novo Authorization for AI-Powered Prostate Cancer Prognostic Software
The risk stratification tool is designed to predict long-term outcomes for patients with non-metastatic prostate cancer.
Why Genomic Tests for Prostate Cancer Need Better Data
A review found gaps remain for genomic classifier tests for their cost-effectiveness, clinical utility, and impact on diverse populations.
Read More
New Blood Test Predicts Prognosis for Advanced Prostate Cancer Patients
The AR-ctDETECT test identifies circulating tumor DNA in advanced prostate cancer patients, providing critical insights for prognostication.
Read More
Researchers Discover Genetic Marker to Identify Aggressive Prostate Cancers Early
A genetic variant in the PSA gene may help improve prostate cancer diagnostics by distinguishing between aggressive and non-aggressive types.
Read More
Early Blood Test Predicts Survival in Patients with Metastatic Prostate Cancer
A study shows that measuring CTCs at the time of metastatic prostate cancer diagnosis can predict survival and guide treatment decisions.
Read More
How Prostate Cancer Screening Advancements Are Reducing Overtreatment
A new prostate cancer screening method could help better predict which patients need to undergo a biopsy, reducing unnecessary procedures.
Read More
GRAIL’s Galleri Test Shows High Accuracy to Detect Aggressive Prostate Cancers
GRAIL’s Galleri multi-cancer early detection test demonstrates strong performance in preferentially identifying aggressive prostate cancers.
Read More
Researchers Discover Novel Nanoparticles in Blood that Could Transform Cancer Diagnosis
A newly discovered class of RNA molecules in extracellular vesicles could serve as biomarkers for non-invasive cancer diagnosis.
Read More
Prostate Cancer: Is AI the Answer to Limit Need of Biopsies?
A retrospective study shows that combining risk markers, MRI evaluation, and AI can more accurately predict prostate cancer risk.
Read More
Why Men Should be Screened for the ‘Breast Cancer Gene’
Studies indicate men with BRCA1 and BRCA2 mutations face significant cancer risks, prompting new national screening guidelines.
Read More
Prostate Cancer Blood Test Equally Effective Across Ethnic Groups
A prostate cancer test using protein and genetic markers improves diagnosis accuracy and reduces unnecessary procedures across ethnic groups.
Read More
Prostate Cancer Risks for Transgender Women on Hormone Therapy
A study warns that transgender women on hormone therapy may have artificially low PSA levels, potentially delaying prostate cancer diagnosis.
Read More
New Urine Test Detects High-Grade Prostate Cancer
The new urine-based test aims to differentiate between slow-growing and aggressive forms of prostate cancer.
Read More
Blood Test Could Improve Active Surveillance for Prostate Cancer
A study found an active surveillance blood test for prostate cancer could predict whether a patient had indolent or aggressive disease.
Read More
Prostate Cancer Screening with a PSA Test Leads to OverdiagnosisÂ
A study investigating a single invitation to a PSA blood test to screen for prostate cancer found it had a small impact on reducing deaths.
Read More
Blood Test and MRI Combo Could Reduce Unnecessary Prostate Biopsies
MRI of the prostate, combined with a blood test, can help find if a prostate lesion is clinically significant cancer, new research suggests.
Read More